Cytokinetics, Inc. (CYTK)
59.81
-1.79
(-2.91%)
USD |
NASDAQ |
Dec 10, 14:24
Cytokinetics Total Assets (Quarterly): 1.437B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Jasper Therapeutics, Inc. | 57.47M |
| Lantheus Holdings, Inc. | 2.276B |
| Bristol Myers Squibb Co. | 96.89B |
| Pfizer Inc. | 208.73B |
| Regeneron Pharmaceuticals, Inc. | 40.17B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.958B |
| Shareholders Equity (Quarterly) | -521.12M |
| Debt to Equity Ratio | -2.297 |
| Current Ratio | 6.876 |
| Net Debt Paydown Yield | -1.21% |